The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population

被引：0
|
作者：
J Rischewski
P v Bismarck
H Kabisch
G Janka-Schaub
T Obser
R Schneppenheim
机构：
[1] University Children's Hospital,Department of Pediatric Haematology and Oncology
来源：
Leukemia | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1528 / 1529
页数：1
相关论文
共 48 条
  • [21] Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial
    Mori, Tetsuya
    Osumi, Tomoo
    Kada, Akiko
    Ohki, Kentaro
    Koga, Yuhki
    Fukano, Reiji
    Fujita, Naoto
    Mitsui, Tetsuo
    Mori, Takeshi
    Saito, Akiko M.
    Nakazawa, Atsuko
    Kobayashi, Ryoji
    Sekimizu, Masahiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 585 - 593
  • [22] Risk of Second Primary Cancer in Patients with B-cell Non-Hodgkin Lymphoma Receiving Rituximab-containing Chemotherapy: A Nationwide Population-based Study
    Cho, Shih-Feng
    Wu, Wan-Hsuan
    Yang, Yi-Hsin
    Chang, Chao-Sung
    ANTICANCER RESEARCH, 2015, 35 (03) : 1809 - 1814
  • [23] Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell Non-Hodgkin's lymphoma
    Cikota, B. M.
    Tukic, Lj. J.
    Tarabar, O. T.
    Magic, Z. M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (04): : 535 - 542
  • [24] A study of the relationship between circulating cytokines (interleukin-2 receptor and tumor necrosis factor receptor 2) and risk of B-cell non-hodgkin lymphoma
    Abd El-Ghani, Sara El-Sayed
    Abido, Heba Youssef
    Tawfik, Nehad Mohamed
    Shaheen, Gehan
    Ellithy, Hend Nabil
    ANNALS OF HEMATOLOGY, 2024, : 665 - 673
  • [25] A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma
    Hapgood, Greg
    Stone, Janey M.
    Zannino, Diana
    George, Anup
    Marlton, Paula
    Prince, Henry Miles
    Hui, Chi-Hung
    Prosser, Ian
    Lewis, Ian D.
    Bradstock, Kenneth
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 904 - 911
  • [26] t(9;14)(p13;q32) involving the PAX-5 gene:: a unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma
    Amakawa, R
    Ohno, H
    Fukuhara, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (02) : 65 - 69
  • [27] FANCA, TP53, and del(5q)/ RPS14 alterations in a patient with T-cell non-Hodgkin lymphoma and concomitant Fanconi anemia and Li-Fraumeni syndrome
    Errichiello, Edoardo
    Mina, Tommaso
    Morbini, Patrizia
    Zecca, Marco
    Zuffardi, Orsetta
    CANCER GENETICS, 2021, 256 : 179 - 183
  • [28] Malnutrition, Sepsis, and Tumor Lysis Syndrome Are Associated with Increased Rate of Acute Mortality in Mature B Cell Non-Hodgkin Lymphoma in a Pediatric Population-Study from Tertiary Care Hospital in Pakistan
    Mansoor, Raheela
    Saeed, Haleema
    Wali, Rabia Muhammad
    Rehman, Palwasha
    Abubakar, Muhammad
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [29] Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
    Hohloch, Karin
    Ziepert, Marita
    Truemper, Lorenz
    Buske, Christian
    Held, Gerhard
    Poeschel, Viola
    Chapuy, Bjoern
    Altmann, Bettina
    EJHAEM, 2020, 1 (01): : 181 - 187
  • [30] Genetic variations in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) gene and the susceptibility to B cell non-Hodgkin lymphoma in Egypt
    Khorshied, M.
    Soliman, N.
    Bakr, S.
    Khorshied, O.
    LEUKEMIA RESEARCH, 2019, 85 : S26 - S27
12345